IONS IONIS PHARMACEUTICALS INC Offer for Sale 8-K Filing 2024 - Stock Offering Ionis Pharmaceuticals filed a preliminary prospectus for a public offering of common stock, highlighting its ongoing development of RNA-targeted medicines and recent advancements in its drug pipeline, including five marketed medicines and nine in Phase 3 development.Get access to all SEC 8-K filings of the IONIS PHARMACEUTICALS INC